Cryostorage of human ovarian tissue: evaluating the storage and disposal pattern over a 22-year period in 2475 patients.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
09 2023
Historique:
received: 01 02 2023
revised: 22 05 2023
accepted: 24 05 2023
medline: 8 9 2023
pubmed: 4 7 2023
entrez: 3 7 2023
Statut: ppublish

Résumé

What are the parameters of age, indications for ovarian tissue cryopreservation, storage characteristics and reasons for tissue disposal in a large cohort of individuals undertaking cryopreservation? The relevant parameters in a single university centre were revised and digitalized in the period from 2019 to 2021. To assess patients' motivation at the end of storage, patients were contacted by letter, e-mails and telephone calls. A group of 2475 patients with stored ovarian tissue were analysed in the time period between 2000 and 2021; the response rate for contact calls and letters was 28.8% (224/777). Where storage had ended (n = 1155), patients had on average stored for 3.8 years and begun storing at age 30 years; the main indications were breast cancer (53%) and lymphoma (17.5%). Of these participants, 2.5% had a transplantation on site, 10.3% transferred their tissue to another cryobank and 11.5% were deceased. The majority of the group (75.7%) ended their storage due to pregnancy (49.1%), a lack of desire to have children (25.9%), storage fees that were too expensive (8.9%), death (8.5%), recurrence of cancer (8.5%), lack of a partner (4%) and fear of surgery in the future (3.1%); 6.7% retrospectively regretted ending storage. The pregnancy rate of 49.1%, resulting from ovarian tissue that was not removed during surgery for scheduled ovarian tissue cryopreservation supports the clinical approach of removing and cryopreserving only 25-50% of one ovary. It is proposed that interdisciplinary counselling should be implemented not only prior to fertility preservation, but also when intending to end storage.

Identifiants

pubmed: 37400319
pii: S1472-6483(23)00337-1
doi: 10.1016/j.rbmo.2023.05.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103239

Informations de copyright

Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Andreas Schallmoser (A)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany. Electronic address: andreas.schallmoser@ukbonn.de.

Rebekka Einenkel (R)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany.

Cara Färber (C)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany.

Vanessa Hüren (V)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany.

Anna Pougin (A)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany.

Norah Emrich (N)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany.

Julia John (J)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany.

Nicole Sänger (N)

Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital of Bonn, Germany. Electronic address: nicole.saenger@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH